Tyler Zeronda
Director of Finance/CFO bei VYNE THERAPEUTICS INC.
Vermögen: 404 451 $ am 31.03.2024
Aktive Positionen von Tyler Zeronda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VYNE THERAPEUTICS INC. | Director of Finance/CFO | 18.06.2021 | - |
| Treasurer | 18.06.2021 | - |
Karriereverlauf von Tyler Zeronda
Ehemalige bekannte Positionen von Tyler Zeronda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Director of Finance/CFO | - | - |
Ausbildung von Tyler Zeronda
| University of Virginia | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director of Finance/CFO | 2 |
| Treasurer | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VYNE THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Börse
- Insiders
- Tyler Zeronda
- Erfahrung
